Medline ® Abstract for Reference 38
of 'Molecularly targeted therapy for metastatic melanoma'
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
Long GV, Grob JJ, Nathan P, et al
Lancet Oncol. 2016;